Professional Documents
Culture Documents
Artculo original
Revista latinoamericana
ABSTRACT
Background: The gestational trophoblastic disease is a group of benign and malignant conditions: Hydatidiform moles result from abnormal fertilization and have been divided into partial, complete and invasive mole based on morphologic, cytogenetic, and clinical features.
Another group are the neoplasms of trophoblast (choriocarcinoma, exaggerated placental site and others). Hydatidiform mole is the most
IUHTXHQWIRUPDQGLWLVPDQLIHVWHGGXULQJWKHUVWWULPHVWHURISUHJQDQF\JHQHUDOO\DVVSRQWDQHRXVDERUWLRQ
Objective: To study the immunohistochemical expression of some markers leading have a better correlation with histological parameters
LGHQWLHGZLWKWKHFRQYHQWLRQDOURXWLQHWHFKQLTXH
Material and methods: Thirty-three cases with diagnosis of trophoblastic diseases from pathological anatomy department, Hospital Escuela
Oscar Danilo Rosales, were studied, as well as 33 cases of products of uterine curettage without trophoblastic disease.
Results: p53 immunoreactivity was stronger in complete mole (++) and choriocarcinoma (+++) than in normal placenta and partial mole.
PLAP was expressed in the apical and basal portion of the plasmatic membrane of sincytiotrophoblast cells. `-hCG was expressed in
decidua, endometrial tissue and compact layer glands.
Conclusions: Pathology predominant diagnosis was of complete mole, with classic characteristics due to its diagnosis during the second
trimester of pregnancy. Vimentin immunohistochemical expression was present in all mesenchymal components of tissues corresponding
to cases and controls. p53 immunostaining was more intense (+++) in cases with choriocarcinoma diagnosis. `-hCG was expressed with
intensity (+++) in cases of complete mole and choriocarcinoma, specially at the cytoplasm of sincytiotrophoblast cells.
Key words: trophoblastic disease, p53, vimentin, PLAP, hCG.
96
Este artculo debe citarse como: Valverde D. Enfermedad trofoEOiVWLFDFODVLFDFLyQKLVWRSDWROyJLFD\FDUDFWHUtVWLFDVLQPXQRKLVtoqumicas con los marcadores p53, `-hCG, PLAP y vimentina.
Patologa Rev Latinoam 2009;47(2):96-102.
La versin completa de este artculo tambin est disponible en:
www.revistasmedicasmexicanas.com.mx
Enfermedad trofoblstica
97
Valverde D
Casa-clona
Dilucin
Recuperacin
P53
Dakocyt/DO7
1:50
PLAP
`-hCG
Vimentina
Dakocyt/8A 9
Dako/A0231
Dakocyt/V9
1:50
1:300
1:50
Horno de
microondas
Autoclave
Autoclave
Autoclave
98
El rango de edad predominante de las pacientes con enfermedad trofoblstica gestacional fue de 20 a 29 aos
(52%), Las pacientes con mola completa y mola parcial
padecieron sangrado transvaginal y tenan, en promedio,
16 semanas de amenorrea. En todos los casos de mola
completa hubo hallazgos histopatolgicos de cisternas e
hiperplasia trofoblstica.
La inmunotincin con vimentina se expres intensamente en todos los componentes mesenquimales representados
HQ OD PXHVWUD HVSHFtFDPHQWH HQ HO HVWURPD GH
YHOORVLGDGHVJXUDV\HQHVSHFLDOHQODVTXHPXHVWUDQEURVLV3DUDODGHFLGXDHOHVWURPDHQGRPHWULDO\HO
msculo liso la inmunotincin fue negativa en clulas trofoblsticas, as como en el epitelio glandular endometrial.
En cuanto a p53 se encontr una expresin (+++) en
clulas trofoblsticas en los dos casos de coriocarcinoma,
FRQQDGRDORVQ~FOHRVGHFpOXODVPDOLJQDV\HQWRGRV
los casos de mola completa con una intensidad (++),
JXUDWDPELpQVHHQFRQWUyHQGHORVFDVRVFRQ
diagnstico de mola parcial y sitio placentario exagerado
y en 50% de las muestras que contenan placenta normal
6HREVHUYyLQPXQRWLQFLyQHQODGHFLGXDJXUD
\HOHSLWHOLRHQGRPHWULDOJXUD
/D H[SUHVLyQ GH K&* VH REVHUYy HQ FpOXODV GHO
epitelio trofoblstico de intensidad (+++) en casos con
Enfermedad trofoblstica
99
Valverde D
100
Anticuerpos
Vimentina
p53
K&*
PLAP
++
33
+++
Enfermedad trofoblstica
REFERENCIAS
1.
2.
3.
4.
5.
6.
7.
8.
9.
10.
11.
12.
13.
CONCLUSIONES
14.
15.
Ezpeleta J, Cousillas A. Enfermedad trofoblstica gestacional: aspectos clnicos y morfolgicos. Rev Esp Patol
2002;35(2):187-200.
Garner EI, Goldstein DP, Feltmate CM, Berkowitz RS. Gestational trophoblastic disease. Clin Obstet Gynecol 2007;50(1):11222.
Silverberg SG, Kurman RJ. Tumors of the uterine corpus and
gestational trophoblastic disease. In: Rosai J, Sobin LJ, editors.
Atlas of tumor pathology: tumors of the uterine corpus and
gestational trophoblastic disease, fasc. 3, ser. 3. Washington
DC: Armed Forces Institute of Pathology; 1992;pp:219-85.
De Agustn P, Ruiz A, Lpez F, Contreras F. Patologa de la
enfermedad trofoblstica. Simposio Enfermedad Trofoblstica
1972; 79-98.
Fox H. Gestational trophoblastic disease. BMJ 1997;314:
363-4.
Philippe E, Dreyfus M. Maladies trophoblastiques gestationnelles. Encycl Med Chir Obsttrique 1998;5070-C-10:12-27.
Grases Pedro J, Tresserra F. Enfermedad trofoblstica de la
gestacin. Rev Obstet Ginecol Venez 2004;64(2):101-13.
Grases PJ. Enfermedad trofoblstica gestacional. Patologa
ginecolgica. Bases para el diagnstico morfolgico. Barcelona: Masson, 2003;pp:567-74.
Lage JM. Gestational trophoblastic disease. In: Robboy SJ,
Anderson MC, Russell P, editors. Pathology of the female reproductive tract. Londres: Churchill Livingstone, 2002;pp:75981.
Fox H. Pathology of the placenta: Major problems in pathology.
2nd ed. Vol 7. London: WB Saunders Co, 1997.
Abike F, Temizkan O, Payasli A, Avsar F, et al. Postmenopausal complete hydatidiform mole: a case report. Maturitas
2008;59(1):95-98.
Rosai J, Ackerman LV. Ackermans surgical pathology. 8th ed.
Vol I. St. Louis: Mosby, 1996;pp:1737-63.
Mazur MT, Kurman RJ. Gestational trophoblastic disease.
Diagnosis of endometrial biopsies and curettings, a practical
approach. 2nd ed. New York: Springer, 2007;pp:67-96.
Shih IM, Mazur MT, Kurman RJ. Gestational trophoblastic
diseases and related lesions. In: Blausteins pathology of the
female tract. 5th ed. New York: Springer, 2002;pp:1193-247.
Gestational trophoblastic disease. The doctors doctor, p.1-15,
Enero 2003. Disponible en: http://www.thedoctorsdoctor.com/
diseases/gestationaltrophoblasticdisease
101
Valverde D
102
31.
32.
33.
34.
35.
36.
37.
38.
39.
40.
41.
42.
cytometry in anembrionic pregnancy and spontaneous abortions. Gynecol Obstet Invest 1999;48:104-7.
Cheville JC, Robinson RA, Benda JA. p53 expression in
placentas with hydropic change and hydatidiform moles. Mod
Pathol 1996;9:392-6.
Haidacher S, Blaschitz A, Desoye G, Dohr G. Inmunohistochemical evidence of p53 protein in human placenta and choriocarcinoma cell lines. Human Reprod
1995;10(4):983-8.
Halperin R, Peller S, Sandbank J, Bukovsky I. Expression of the
p53 gene and apoptosis in gestational trophoblastic disease.
Placenta 2000;21(1):58-62.
Fulop V, Mok SC, Genest DR, Gati I, et al. p53, p21, Rb
and amdm2 oncoproteins. Expression in normal placenta,
partial and complete, and choriocarcinoma. J Reprod Med
1998;43(2):119-27.
Al-Bozom IA. p53 and Bcl-2 oncoprotein expression in placentas with hydropic changes and partial and complete moles.
APMIS 2001;108(11):756-60.
Cohen M, Meissner A, Haenggeli L, Irminger-Finger I, Bischof
36WDWXVRISLQUVWWULPHVWHUF\WRWURSKREODVWLFFHOOV0RO
Hum Reprod 2007;13(2):111-6.
Kale A, Sylemez F, Ensari A. Expressions of proliferation
markers (Ki-67, proliferating cell nuclear antigen, and silverstaining nucleolar organizer regions) and of p53 tumor protein
in gestational trophoblastic disease. Am J Obstet Gynecol
2001;184(4):567-74.
Halperin R, Peller S, Sandbank J, Bukovsky I, Schneider
D. Expression of the p53 gene and apoptosis in gestational
trophoblastic disease. Placenta 2000;21(1):58-62.
Martinazzi S, Zampieri A, Todeschin P, Vegetti PL, et al. [Correlation of the histological and cytogenetic pictures in placental
tissue from early abortion. Does immunohistochemistry have
a role?]. Pathologica 1996;88(4):275-85.
Leitner K, Szlauer R, Ellinger I, Ellinger A, et al. Placental alkaline phosphatase expression at the apical and basal plasma
membrane in term villous trophoblasts. J Histochem Cytochem
2001;49(9):1155-64
Brescia RJ, Kurman RJ, Main CS, Surti U, Szulman AE. Immunocytochemical localization of chorionic gonadotropin,
placental lactogen, and placental alkaline phospatase in the
diagnosis of complete and parcial hydatidiform mole. Int J
Gynecol Pathol 1987;6(3):213-29.
Salehnia M, Farzad TR, Tachikhani M, Torghaban SS, Al-Traihi
T. Alkaline phosphatase, histochemistry and biochemistry in
the diagnosis of complete hydatidiform mole. Pathol Oncol
Res 2000;6(2):105-10.